Galiximab is a monoclonal antibody designed for the treatment of B-cell lymphoma. As of September 2009, it is undergoing Phase III clinical trials. The drug is a chimeric antibody from Macaca irus and Homo sapiens. Wikipedia

Biogen Idec doesn't have any insights (yet...).

Shall we increase our level of intimacy?

40,782,132 ideas and insights to help you find what’s next.

Log in Sign up

Shall we increase our level of intimacy?

40,782,132 ideas and insights to help you find what’s next

Create Free Account

Already a user?  Log in